Literature DB >> 2727616

Subcutaneous and muscle blood flow during dopamine infusion in man.

P Eliasen1, P Klemp, H Vagn Nielsen, P Crone.   

Abstract

Subcutaneous fat tissue and skeletal-muscle blood flow was measured in six male volunteers using the local 133Xe-washout method. Measurements were obtained before and during intravenous dopamine infusion in non-pressor (1 microgram kg-1 min-1) and pressor infusion rates (3-6 micrograms kg-1 min-1). During non-pressor infusion rate the systolic and diastolic arterial pressure and heart rate remained unchanged. When pressor dose dopamine was infused the systolic and mean arterial pressures increased significantly, whereas the diastolic pressure and the heart rate were left unchanged. The blood flow increased progressively from control values in both subcutis (control: 2.9 +/- 0.2, non-pressor: 5.0 +/- 1.6, pressor: 9.1 +/- 0.4 ml min-1 100 g-1, mean +/- SEM) and in skeletal muscle (control: 1.2 +/- 0.2, non-pressor: 1.5 +/- 0.2, pressor: 1.9 +/- 0.4 ml min-1 100 g-1, mean +/- SEM) and was significantly different from baseline values at any dopamine infusion rate. Side-effects were observed only at pressor dose infusion. It is concluded that dopamine in humans seems to possess vasodilatoric properties in subcutaneous fat tissue, and in skeletal muscles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2727616     DOI: 10.3109/00365518909089076

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

2.  Pramipexole alters thermoregulation in restless legs syndrome.

Authors:  Aaro V Salminen; Ville Rimpilä; Olli Polo
Journal:  J Clin Sleep Med       Date:  2014-12-15       Impact factor: 4.062

3.  Peripheral Dopamine in Restless Legs Syndrome.

Authors:  Ulrike H Mitchell; J Daniel Obray; Erik Hunsaker; Brandon T Garcia; Travis J Clarke; Sandra Hope; Scott C Steffensen
Journal:  Front Neurol       Date:  2018-03-15       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.